Serologic responses to Pneumocystis carinii antigens in health and disease
- PMID: 2299209
- DOI: 10.1093/infdis/161.2.296
Serologic responses to Pneumocystis carinii antigens in health and disease
Abstract
Serum antibodies to human Pneumocystis carinii antigens were measured in greater than 400 specimens from different population groups by the immunoblotting technique. Serologic responses varied during the first 2 years of life, but in children greater than or equal to 2 1/2 years and in adults antibodies to a 40-kDa band were found in greater than 85% of the specimens; antigens to bands of 66, 92, and 116 kDa were also detected frequently. The prevalence of serum antibodies in immunosuppressed patients varied at different institutions and was usually lower than that of healthy controls. Seven (41%) of 17 patients with single episodes of pneumocystosis and 13 (93%) of 14 patients with recurrent episodes followed sequentially developed active serum IgM and/or IgG antibody responses to the 40-kDa antigen. Serologic responses to P. carinii were also detected, though less frequently, by immunofluorescence. These data suggest that the 40-kDa antigen is a major marker of P. carinii infection and that immunoblotting is useful in measuring serum antibody responses to the organism in both normal and immunocompromised hosts.
Similar articles
-
Antibody response to a major human Pneumocystis carinii surface antigen in patients without evidence of immunosuppression and in patients with suspected atypical pneumonia.Eur J Clin Microbiol Infect Dis. 1993 Feb;12(2):105-9. doi: 10.1007/BF01967583. Eur J Clin Microbiol Infect Dis. 1993. PMID: 8500476
-
Pneumocystis carinii: immunoblotting and immunofluorescent analyses of serum antibodies during experimental rat infection and recovery.Exp Parasitol. 1987 Jun;63(3):319-28. doi: 10.1016/0014-4894(87)90179-2. Exp Parasitol. 1987. PMID: 3556208
-
Application of immunoblotting to detect soluble Pneumocystis carinii antigen(s) in bronchoalveolar lavage of patients with Pneumocystis pneumonia and AIDS.J Clin Pathol. 1990 Jul;43(7):584-6. doi: 10.1136/jcp.43.7.584. J Clin Pathol. 1990. PMID: 2380406 Free PMC article.
-
Immunological features of Pneumocystis carinii infection in humans.Clin Diagn Lab Immunol. 1999 Mar;6(2):149-55. doi: 10.1128/CDLI.6.2.149-155.1999. Clin Diagn Lab Immunol. 1999. PMID: 10066645 Free PMC article. Review. No abstract available.
-
Pneumocystis carinii: a misunderstood opportunist.Eur J Clin Microbiol. 1984 Jun;3(3):169-73. doi: 10.1007/BF02014871. Eur J Clin Microbiol. 1984. PMID: 6381045 Review. No abstract available.
Cited by
-
Antibody responses against Pneumocystis jirovecii in health care workers over time.Emerg Infect Dis. 2013 Oct;19(10):1612-9. doi: 10.3201/eid1910.121836. Emerg Infect Dis. 2013. PMID: 24048016 Free PMC article.
-
Extrapulmonary pneumocystosis.Clin Microbiol Rev. 1997 Jul;10(3):401-18. doi: 10.1128/CMR.10.3.401. Clin Microbiol Rev. 1997. PMID: 9227859 Free PMC article. Review.
-
Primary pneumocystis infection in infants hospitalized with acute respiratory tract infection.Emerg Infect Dis. 2007 Jan;13(1):66-72. doi: 10.3201/eid1301.060315. Emerg Infect Dis. 2007. PMID: 17370517 Free PMC article.
-
Sterols of Pneumocystis carinii hominis organisms isolated from human lungs.Clin Diagn Lab Immunol. 1999 Nov;6(6):970-6. doi: 10.1128/CDLI.6.6.970-976.1999. Clin Diagn Lab Immunol. 1999. PMID: 10548595 Free PMC article.
-
Characterization of transmission of Pneumocystis carinii f. sp. muris through immunocompetent BALB/c mice.Infect Immun. 2003 Jul;71(7):3852-6. doi: 10.1128/IAI.71.7.3852-3856.2003. Infect Immun. 2003. PMID: 12819069 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources